SCI Abstract

search
+
Posterior Reversible Encephalopathy Syndrome after Allogeneic Stem Cell Transplantation in Pediatric Patients with Fanconi Anemia, a Prospective Study
Volume 26, Issue 12, December 2020, Pages e316-e321Highlights•Individuals with Fanconi anemia have a higher incidence of p...
BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions
BiCNU (carmustine), etoposide, Ara-C, melphalan (BEAM) and Campath conditioning was developed to reduce the high transplan...
Incidence and Outcome of Late Relapse after Allogeneic Stem Cell Transplantation for Myelofibrosis
Volume 26, Issue 12, December 2020, Pages 2279-2284Highlights•Late relapse after 5 years occurs in about 14% of myelofibro...
Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major
Volume 26, Issue 12, December 2020, Pages 2285-2291Highlights•HLA-matched transplant in pediatric patients with hemoglobin...
Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in Fanconi Anemia: Improving Outcomes with Improved Supportive Care in India
Volume 26, Issue 12, December 2020, Pages 2292-2298Highlights•Haploidentical stem cell transplantation with post-transplan...
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas
Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a valid option in patients with refractory lymphomas. HLA...
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
Transplant-associated thrombotic microangiopathy (taTMA) is a systemic vascular illness associated with significant morbid...
Impact of CD34 Cell Dose and Conditioning Regimen on Outcomes after Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia
Volume 26, Issue 12, December 2020, Pages 2311-2317Highlights•Hematopoietic stem cell transplantation from haploidentical ...
Pre-Hematopoietic Stem Cell Transplantation Lung Computed Tomography as an Alternative to the Pulmonary Function Test during the COVID-19 Pandemic
Volume 26, Issue 12, December 2020, Pages 2318-2322Highlights•The pulmonary function test (PFT) is an important test for r...
Clinical and Neuroimaging Correlates of Post-Transplant Delirium
Delirium is common among adults undergoing hematopoietic stem cell transplantation (HCT), although the clinical and neuroi...
Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplantation Recipients
The use of potentially inappropriate medications (PIMs) using Beers criteria and its impact on older allogeneic hematopoie...
Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age
Hematopoietic cell transplantation (HCT) is an effective treatment for many hematologic malignancies, and its utilization ...
Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation for Mature T Cell and Natural Killer Cell Neoplasms in the Kyoto Stem Cell Transplantation Group
Volume 26, Issue 12, December 2020, Pages 2346-2358Highlights•Allogeneic hematopoietic stem cell transplantation is benefi...
The Effect of Granulocyte Colony-Stimulating Factor Use on Hospital Length of Stay after Allogeneic Hematopoietic Cell Transplantation: A Retrospective Multicenter Cohort Study
Volume 26, Issue 12, December 2020, Pages 2359-2364Highlights•Empiric granulocyte colony-stimulating factor (G-CSF) therap...
Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study
Volume 26, Issue 12, December 2020, Pages 2365-2371Highlights•Related donors were more certain about and satisfied with th...
The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study
Multiple myeloma (MM) is a plasma cell neoplasm characterized by destructive bony lesions, anemia, and renal impairment. A...
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia
Volume 26, Issue 12, December 2020, Pages e322-e327Highlights•The combination of hypomethylating agents with the selective...
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents
Volume 26, Issue 12, December 2020, Pages e328-e332Highlights•Allogeneic stem cell transplantation (SCT) did not offer a s...
Letter to the Editor Regarding “Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma”
Volume 26, Issue 12, December 2020, Pages e333-e334Previous article in issueNext article in issueRecommended articlesCitin...
Response to Letter to Editor Regarding “Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma”
Volume 26, Issue 12, December 2020, Pages e335-e336Previous article in issueNext article in issueRecommended articlesCitin...
format_indent_increase